3919 V
Pill imprint 3919 V has been identified as Levothyroxine sodium 125 mcg (0.125 mg).
Levothyroxine is used in the treatment of underactive thyroid; hypothyroidism, after thyroid removal; hashimoto's disease; tsh suppression; thyroid suppression test (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy.
Levothyroxine 125 mcg (0.125 mg) is not subject to the Controlled Substances Act.
See also related documents.
Levothyroxine sodium Images
- Imprint:
-
3919 V
- Strength:
- 125 mcg (0.125 mg)
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Thyroid drugs
- Pregnancy Category:
- A - Studies show no risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- United Research Laboratories/Mutual Pharmaceutical Company
Advertisement
More Levothyroxine Sodium resources
- Levothyroxine
- Levothyroxine (Wolters Kluwer)
- Levothyroxine Capsules (Wolters Kluwer)
- Levothyroxine Solution (Wolters Kluwer)
- levothyroxine (Cerner Multum)
- levothyroxine (Micromedex) - Includes Dosage Information
- levothyroxine Injection (Micromedex) - Includes Dosage Information
- Levothyroxine Sodium (AHFS DI)
- Levothyroxine (FDA)
- Novothyrox (FDA)
- Levothyroxine Sodium (T4; L-thyroxine) (Wolters Kluwer)
Search Again
